Summary of Increased oHSV Replication in Cancer Cell Lines Pre-treated with HDAC Inhibitors.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
No increase (-) or increases in replication of >2 fold (+), >5 fold (++) and >10 fold (+++) are shown. 1For breast cancer. 2Clinically approved for the treatment of cutaneous T cell lymphoma. 3Also inhibits the Class IIa enzyme HDAC 9.
创建时间：
2014-03-20
